Navigation Links
Research Report on BioClinica, Inc. as Speculative Buy
Date:11/29/2009

ATLANTA, Nov. 29 /PRNewswire/ -- The following is an investment opinion release issued by Intellivest Securities Research, Inc.

Intellivest Securities Research, Inc., ("ISR") a Georgia registered investment advisor, has published a Report on BioClinica, Inc. ( BIOC) which serves companies in the pharmaceutical, biotechnology and medical device industries. A primary service is helping their clients manage, process and submit medical imaging portions of their submissions relating to their clinical trials to regulators, primarily the U.S. Food and Drug Administration and comparable European agencies, to evaluate product efficacy and safety. BioClinica has provided services to more than 130 firms in connection with over 2,000 clinical partners since its founding in 1990.

The Research Report rates BioClinica, Inc. as a Speculative Buy because the FDA and other regulators are encouraging more clinical trial data to be submitted in an electronic format. As an early mover in this area, BioClinica is well positioned to exploit this trend. BIOC has a strong balance sheet and an attractive valuation. It has no debt, adequate cash, growing positive cash flow and enjoys significant operating leverage. BioClinica's shares are currently trading around two times book value and one times revenue. It has an experienced, highly competent management team, who, along with Board members, own about 9% of outstanding shares. BIOC has worked with the world's leading bio-pharmaceutical companies including three that are Dow Jones Industrial Average components: Johnson & Johnson, Merck, and Pfizer.

BioClinica has recently completed the integration of its two most recent acquisitions both of which should be accretive in 2010. BIOC reported positive results for the third quarter ending 9/30.

The Report states that BioClinica faces a number of risks including the uncertainty facing the entire pharmaceutical industry as a result of proposed health reform legislation.

About the Report

Intellivest Securities Research, Inc.'s research is distributed by Intellivest Securities, Inc., (FINRA, SIPC, RIA, SIFMA), whose Office of Supervisory Jurisdiction is located at 1540 Chase Court, Riverdale, GA. 30296-2610. Please read the Research Report for certain disclaimers and disclosures. Daniel H. Kolber is the author of the Report and www.DowJonesMonitor.com, a daily blog that aggregates articles about the Dow Jones 30 components (not affiliated with Dow Jones). He holds these licenses: Series 24, 27, 87, 53, 4, 79, 65; is a member of the Georgia, New York, Florida and Virginia Bars, and has the B.A. from Boston University, the J.D. from University of Virginia School of Law and the Ll.M. from New York University School of Law.

Intellivest Securities Research, Inc.'s (CRD #147288) research is distributed as third party research by its affiliate, Intellivest Securities, Inc. (CRD #145022) which is a member of the Financial Industry Regulatory Authority,.

www.intellivestsecurities.com

SOURCE Intellivest Securities Research, Inc.


'/>"/>
SOURCE Intellivest Securities Research, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Research sheds light on workings of anti-cancer drug
2. Dr. Douglas Macmillan Now Providing LUMINEERS at Research Triangle Dental
3. MISSION Skincare(R) Supports GNCs Efforts To Raise Money for St. Jude Childrens Research Hospital(R)
4. Researchers identify proteins in lung cancer cells that may provide potential drug targets
5. Researchers Identify Possible Causative Mutation for Crohn's Disease: Crohn's & Colitis Foundation Annual Conference to Present Emerging Research
6. Research Yields Clues to Severe Form of Sinusitis
7. AIDS research reveals a lack of family-planning programs in Uganda
8. Ann Taylor Stores Corp. Returns To St. Jude Childrens Research Hospitals Thanks and Giving Campaign(R) For The Third Year
9. New research shows versatility of amniotic fluid stem cells
10. Johns Hopkins researchers track down protein responsible for chronic rhinosinusitis with polyps
11. Top 10 Food Tips for the Holidays from the National Foundation for Cancer Research
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... ... June 27, 2016 , ... TopConsumerReviews.com recently awarded their highest five-star rating to ... of individuals in the United States and Canada wear eyeglasses. Once considered to be ... vision and make a fashion statement. Even celebrities use glasses as a way of ...
(Date:6/26/2016)... , ... June 26, 2016 , ... On June 10-11, ... of the 2016 Cereal Festival and World’s Longest Breakfast Table in Battle Creek, MI, ... the city’s history as home to some of the world’s leading providers of cereal ...
(Date:6/26/2016)... , ... June 26, 2016 , ... PawPaws brand ... new product that was developed to enhance the health of felines. The formula is ... The two main herbs in the PawPaws Cat Kidney Support Supplement Soft ...
(Date:6/26/2016)... Lake Orion, Clarkston, Michigan (PRWEB) , ... June ... ... direction with respect to fertility once they have been diagnosed with endometriosis. These ... tolerable intercourse but they also require a comprehensive approach that can help for ...
(Date:6/25/2016)... ... June 25, 2016 , ... Austin residents seeking Mohs surgery services, ... Mohs Surgery and to Dr. Russell Peckham for medical and surgical dermatology. , Dr. ... skin cancer. The selective fellowship in Mohs Micrographic Surgery completed by Dr. Dorsey was ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... Research and Markets has announced the addition of the ... to 2022" report to their offering. ... financial data derived from varied research sources to present unique ... on the market during the next five years, including a ... markets, regional and country level analysis. The report provides a ...
(Date:6/23/2016)... , June 23, 2016 Research and ... News Issue 52" report to their offering. ... influenza treatment creates a favourable commercial environment for MedImmune to ... patient base that will serve to drive considerable growth for ... would serve to cap sales considerably, but development is still ...
(Date:6/23/2016)... Calif. , June 23, 2016 ... CST on Thursday, July 7, 2016 , , , , ... ) , , , , EXPERT PANELISTS:  , , ... Naik; Senior Industry Analyst, Christi Bird; Senior Industry Analyst, Divyaa Ravishankar ... The global pharmaceutical industry is witnessing an exceptional ...
Breaking Medicine Technology: